Point72 Asset Management, L.P. - 01 Apr 2025 SCHEDULE 13G Report for Regulus Therapeutics Inc. Common Stock, par value $0.001 per share (RGLS)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- RGLS
- Shares outstanding
- 66,505,186 shares
- Disclosed Ownership
- 3,923,806 shares
- Ownership
- 5.9%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Apr 2025, 16:30:22 UTC
- Date of event
- 01 Apr 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 5.9% | 3,923,806 | 0 | 3,923,806 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 5.9% | 3,923,806 | 0 | 3,923,806 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 5.9% | 3,923,806 | 0 | 3,923,806 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |